ASTEC — Astec Lifesciences Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsAdventurousSmall CapMomentum Trap

Annual income statement for Astec Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,549	6,766	6,282	4,582	3,813
Cost of Revenue
Gross Profit	1,781	2,369	1,695	964	394
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	4,690	5,569	5,850	5,002	4,912
Operating Profit	859	1,197	431	-421	-1,099
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	891	1,211	349	-617	-1,410
Provision for Income Taxes
Net Income After Taxes	651	899	256	-469	-1,347
Minority Interest
Net Income Before Extraordinary Items
Net Income	650	899	256	-469	-1,348
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	650	899	256	-469	-1,348
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	33	45.5	13.1	-23.7	-68.9
Dividends per Share